| Trial ID: | L0541 |
| Source ID: | IRCT2017060212789N14
|
| Associated Drug: |
Rosvastatin
|
| Title: |
The effect of Rosvastatin on steatosis and fibrosis in patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial study
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease (NAFLD). <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Control Group: patients received placebo daily plus standard treatment for fatty liver disease. Intervention 2: Intervention Group: patients received 10 mg Rosvastatin daily plus standard treatment for fatty liver disease.;Treatment - Drug
|
| Outcome Measures: |
Steatosis of liver. Timepoint: Before intervention, six month after intervention. Method of measurement: Fibroscan.;Fibrosis of liver. Timepoint: Before intervention, six month after intervention. Method of measurement: Fibroscan.ALT. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;AST. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;LDL. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;HDL. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;Triglyceride. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;Bilirubin. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;Blood urea. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.;Blood creatinine. Timepoint: Before intervention, six month after intervention. Method of measurement: Blood examination.
|
| Sponsor/Collaborators: |
Vice Chancellor for Research of Kurdistan University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years70 years
|
| Phases: |
Phase 3
|
| Enrollment: |
40
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
12/06/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/12802
|
